The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mamedov M.N.

National Medical Research Center for Therapy and Preventive Medicine

Tsygankova O.V.

Novosibirsk State Medical University

Kanorsky S.G.

Kuban State Medical University

Khorolets E.V.

Rostov State Medical University

Akhundova H.R.

National Medical Research Center for Therapy and Preventive Medicine

Kutsenko V.A.

National Medical Research Center for Therapy and Preventive Medicine

Kovalenko Yu.S.

Kuban State Medical University

Vagapova G.R.

Kazan State Medical Academy — branch of the Russian Medical Academy of Postgraduate Education

Orlova L.F.

Kazan State Medical Academy — branch of the Russian Medical Academy of Postgraduate Education

Nasyrtdinova A.D.

Republican Endocrinology Center of the G.G. Kuvatov Republican Clinical Hospital

Bontsevich R.A.

Mari State University

Tokareva O.A.

Mari State University

Suplotova L.A.

Tyumen State Medical University

Tishkovets S.V.

Medical Institute of the Buryat State University

Kostrova E.A.

Medical Institute of the Buryat State University

Bagdasaryan A.G.

Moscow City Polyclinic

Serebryakova O.V.

Chita State Medical Academy

Itinson E.M.

Kursk Regional Multidisciplinary Clinical Hospital

Dobronravov M.Yu.

V.I. Voynov Regional Clinical Hospital

Saneeva G.A.

Stavropol State Medical University

Manishchenkova Yu.A.

St. Luke’s Leningrad State Medical University

Analysis of risk factors for cardiovascular diseases in patients with type 1 diabetes mellitus

Authors:

Mamedov M.N., Tsygankova O.V., Kanorsky S.G., Khorolets E.V., Akhundova H.R., Kutsenko V.A., Kovalenko Yu.S., Vagapova G.R., Orlova L.F., Nasyrtdinova A.D., Bontsevich R.A., Tokareva O.A., Suplotova L.A., Tishkovets S.V., Kostrova E.A., Bagdasaryan A.G., Serebryakova O.V., Itinson E.M., Dobronravov M.Yu., Saneeva G.A., Manishchenkova Yu.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2026;29(2): 56‑62

Read: 772 times


To cite this article:

Mamedov MN, Tsygankova OV, Kanorsky SG, et al. Analysis of risk factors for cardiovascular diseases in patients with type 1 diabetes mellitus. Russian Journal of Preventive Medicine. 2026;29(2):56‑62. (In Russ.)
https://doi.org/10.17116/profmed20262902156

Recommended articles:
The type 1 diabetes mellitus treatment. Russian Journal of Preventive Medi­cine. 2025;(8):131-137
Cost-effectiveness analysis of screening for type 1 diabetes in children in the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2026;(2):123-138

References:

  1. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. Geneva, 1999.
  2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. 2021.
  3. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1): S13-S28.  https://doi.org/10.2337/dc19-S002
  4. Lampasona V, Liberati D. Islet Autoantibodies. Current Diabetes Reports. 2016;16(6):53.  https://doi.org/10.1007/s11892-016-0738-2
  5. Saxarny`j diabet 1 tipa. Klinicheskie rekomendacii u vzrosly`x. Pod red. Dedova II. M., 2022. Accessed December 22, 2025. (In Russ.). https://base.garant.ru/406534305/
  6. Gregory GA, Robinson TIG, Linklater SE, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes and Endocrinology. 2022;10(10):741-760.  https://doi.org/10.1016/S2213-8587(22)00218-2
  7. Algoritmy` specializirovannoj medicinskoj pomoshhi bol`ny`m saxarny`m diabetom. Pod red. II Dedova, MV Shestakovoj, AYu Majorova. 11-j vy`pusk. M.; 2023. (In Russ.). https://doi.org/10.14341/DM13042
  8. Vrints C, Andreotti F, Koskinas KC, et al. ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal. 2024 29;45(36):3415-3537. https://doi.org/10.1093/eurheartj/ehae177
  9. Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392:477-486.  https://doi.org/10.1016/S0140-6736(18)31506-X
  10. Miller RG, Costacou T, Orchard TJ. Risk factor modeling for cardiovascular disease in type 1 diabetes in the Pittsburgh epidemiology of diabetes complications (EDC) study: a comparison with the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (DCCT/EDIC). Diabetes. 2019;68:409-419.  https://doi.org/10.2337/db18-0515
  11. Caxarny`j diabet tipa 1: realii i perspektivy`. Pod red. II Dedova, MV Shestakovoj. M.: OOO «Izdatel`stvo «Medicinskoe informacionnoe agentstvo»; 2016. (In Russ.).
  12. Holt RIG, DeVries JH, Hess-Fischl A, et al. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589-2625. https://doi.org/10.2337/dci21-0043
  13. Marx N, Federici M, Schütt K, et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. European Heart Journal. 2023;44(39):4043-4140. https://doi.org/10.1093/eurheartj/ehad192
  14. Yoo J, Jeon J, Baek M, et al. Impact of statin treatment on cardiovascular risk in patients with type 1 diabetes: a population-based cohort study. Journal of Translational Medicine. 2023;21:806.  https://doi.org/10.1186/s12967-023-04691-6
  15. Balanova YuA, Shalnova SA, Imaeva AE, et al. Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study). Racional’naja Farmakoterapija V Kardiologii. 2019;15(4):450-66. (In Russ.). https://doi.org/10.20996/1819-6446-2019-15-4-450-466
  16. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. 2022 Prevention of chronic noncommunicable diseases in the Russian Federation. National guidelines. Kardiovaskuljarnaja terapija i profilaktika. 2022;21(4):3235. (In Russ.). https://doi.org/10.15829/1728-8800-2022-3235
  17. Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions. Circulation. 2018;137(20): 2166-78.  https://doi.org/10.1161/CIRCULATIONAHA.117.029652
  18. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952.  https://doi.org/10.1016/S0140-6736(04)17018-9
  19. Mamedov MN, Sushkova LT, Isakov RV, et al. Assessment of the level of chronic stress in the adult population of the Vladimir region. Rossijskij kardiologicheskij zhurnal. 2023;28(11):5643. (In Russ.). https://doi.org/10.15829/1560-4071-2023-5643

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.